Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4523913 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1143914 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4530186 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4530966 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4516780 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4530573 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4538868 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4524633 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4533168 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4526300 | 1.00 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117241670-A | Antimicrobial surfaces and related methods | 汉高股份有限及两合公司 | 2023-12-15 | — | — | CN | claimed |
| EP-4211194-A1 | ANTI-MICROBIAL SURFACES AND RELATED METHODS | NBD Nanotechnologies, Inc. (US) | 2023-07-19 | — | — | EP | claimed |
| WO-2022055965-A9 | ANTI-MICROBIAL SURFACES AND RELATED METHODS | Nbd Nanotechnologies Inc. (US) | 2022-05-27 | — | — | WO | claimed |
| WO-2022055965-A1 | ANTI-MICROBIAL SURFACES AND RELATED METHODS | Nbd Nanotechnologies Inc. (US) | 2022-03-17 | — | — | WO | claimed |
| EP-3931269-A1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | NBD Nanotechnologies, Inc. (US) | 2022-01-05 | — | — | EP | claimed |
| EP-3801928-A1 | INVISIBLE FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | Nbd Nanotechnologies, Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| US-20200277513-A1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | HENKEL AG & CO. KGAA (DE) | 2020-09-03 | — | — | US | claimed |
| US-12577413-B2 | Anti-microbial surfaces and related methods | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| US-12280395-B2 | Process for forming a coating | HENKEL AG & CO. KGAA (DE) | 2025-04-22 | — | — | US | disclosed |
| US-20250084255-A1 | ANTI-MICROBIAL SURFACES AND RELATED METHODS | HENKEL AG & CO KGAA (DE) | 2025-03-13 | — | — | US | disclosed |
| US-12163050-B2 | Invisible-fingerprint coatings and process for forming same | HENKEL AG & CO. KGAA (DE) | 2024-12-10 | — | — | US | disclosed |
| EP-4400551-A1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | Henkel AG & Co. KGaA (DE) | 2024-07-17 | — | — | EP | disclosed |
| EP-3931269-B1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | HENKEL AG & CO KGAA (DE) | 2024-06-26 | — | — | EP | disclosed |
| EP-3931269-A1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | NBD Nanotechnologies, Inc. (US) | 2022-01-05 | — | — | EP | disclosed |
| WO-2021188135-A1 | PROCESS FOR FORMING A COATING | NBD NANOTECHNOLOGIES, INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| EP-3801928-A1 | INVISIBLE FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | Nbd Nanotechnologies, Inc. (US) | 2021-04-14 | — | — | EP | disclosed |
| CN-112218728-A | Invisible fingerprint coating and forming method thereof | NBD纳米技术公司 | 2021-01-12 | — | — | CN | disclosed |
| US-20200277513-A1 | INVISIBLE-FINGERPRINT COATINGS AND PROCESS FOR FORMING SAME | HENKEL AG & CO. KGAA (DE) | 2020-09-03 | — | — | US | disclosed |
| US-20090123516-A1 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2009-05-14 | — | — | US | disclosed |
| WO-2007019478-A2 | DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS - THERAPEUTIC SAMS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577413-B2 | Anti-microbial surfaces and related methods | SMC3, MSR1, SPOUT1 | LMNA 2347/4885ALDH1A1 1948/4885HSD17B10 1774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.